Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset
Publication date: December 2026 Source: ESMO Real World Data and Digital Oncology, Volume 14 Author(s): D. Hamze, S. Mishra, A. Mohsin, S. Minuit, E.D. Gamsiz Uzun, J.L. Warner
Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset. // ESMO Real World Data and Digital Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949820126000986?dgcid=rss_sd_all
Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset. ESMO Real World Data and Digital Oncology. https://www.sciencedirect.com/science/article/pii/S2949820126000986?dgcid=rss_sd_all
“Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset.” ESMO Real World Data and Digital Oncology.
@article{article44841,
title = {Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset},
journal = {ESMO Real World Data and Digital Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949820126000986?dgcid=rss_sd_all}
}